Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753399 Therapeutic compounds

Patent 11753399 was granted and assigned to Gilead Sciences on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jiayao Li

Gediminas Brizgys

Winston C. Tse

Michael Graupe

Chienhung Chou

Eda Canales

Roland D. Saito

Qiaoyin Wu

...

Date of Patent

September 12, 2023

Patent Application Number

17584643

Date Filed

January 26, 2022

Patent Citations

US Patent 8835488 Opioid receptor ligands and methods of using and making same

US Patent 7390791 Prodrugs of phosphonate nucleotide analogues

US Patent 7803788 Prodrugs of phosphonate nucoleotide analogues

US Patent 8263627 Pyridyl amide T-type calcium channel antagonists

US Patent 8748412 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

US Patent 8754065 Tenofovir alafenamide hemifumarate

US Patent 9012441 Therapeutic compounds

US Patent 9050344 Therapeutic compounds

...

Patent Citations Received

US Patent 12122765 Methods and intermediates for preparing therapeutic compounds

0

US Patent 11944611 Capsid inhibitors for the treatment of HIV

0

US Patent 12077537 Capsid inhibitors for the treatment of HIV

0

US Patent 12084467 Therapeutic compounds for HIV virus infection

0

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753399 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.